Dr. Vinnedge tests novel breast cancer therapeutics and works to identify biomarkers of disease and disease progression from patient samples.

Ashley has a BS in biological studies from the University of Cincinnati. She starting working at Cincinnati Children’s Hospital in 2016 and joined the Privette Vinnedge lab in 2022. She uses cell culture and mouse models to understand the molecular mechanism that drive DEK-induced proliferation in mammary epithelial cells.

Miranda Combs has a BS in biological sciences from Northern Kentucky University and joined the lab in 2016 as a research assistant. She uses cell culture and mouse models to study the oncogenic roles of DEK and how DEK expression creates downstream paracrine signals to create a pro-tumorigenic micro environment.

Evan Page joined the team in the spring of 2022 as a student II position. He is currently a senior at Northern Kentucky University and is pursuing a degree in biological sciences with a focus in biochemistry. He provides valuable technical assistance to support the lab and studies the oncogenic mechanisms of DEK over-expression.